We are seeing more and more organisations exploring secondary manufacturing partnerships, not necessarily to replace existing suppliers, but to expand capacity and reduce risk
Medication Delivery and Support : Once prescribed, our team handles prior authorization for tirzepatide with your insurer
I need legitimate data in order for me to make a decision
In the SURMOUNT 2 trial, tirzepatide given once weekly produced an average weight loss of nearly 15 percent over 72 weeks, yet some participants still reported hunger while on treatment
This discovery led to the development of exenatide, the first GLP-1 receptor agonist approved for type 2 diabetes in 2005
When to Speak to Your GP or Pharmacist Contact your GP or prescribing clinician if you experience: Severe or persistent nausea and vomiting that prevents you from taking your regular medications or staying hydrated New or worsening reflux symptoms despite taking omeprazole as prescribed Severe abdominal pain , particularly if constant or radiating to your back, which could indicate pancreatitis (a rare but serious side effect of GLP-1 agonists) Pain in the upper right abdomen, fever, jaundice, pale stools or dark urine , which could indicate gallbladder problems (more common with GLP-1 agonists) Difficulty swallowing or a sensation of food sticking in your chest or throat Unexplained weight loss beyond what is expected with Wegovy, or inability to maintain adequate nutrition Signs of gastrointestinal bleeding , including black tarry stools, vomiting blood, or severe anaemia symptoms (extreme fatigue, breathlessness, pale skin) Symptoms of low magnesium if you have been on omeprazole long-term, such as muscle cramps, tremors, irregular heartbeat, or seizures Seek urgent help via NHS 111 or call 999 for severe abdominal pain, significant vomiting of blood, large amounts of black tarry stools, or if you feel faint or extremely unwell
